ONCY
Oncolytics Biotech·NASDAQ
--
--(--)
--
--(--)
4.74 / 10
Netural
Capital flows are robust (score 7.47/10), with positive trends across block, small, large, and extra-large orders, despite a slight negative medium-flow pattern. Analyst sentiment is overwhelmingly bullish with a 100% Strong Buy rating from HC Wainwright & Co., though historical win rates are low. This combination of strong liquidity and optimistic ratings offsets some fundamental weaknesses.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-17
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for ONCY?
- ONCY holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 4.74/10 (Netural).
